|
|
Article: Study findings from J. Grosse et al broaden understanding of clinical trial research.(Clinical report)
- Article from:
- Biotech Week
- Article date:
- September 9, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Investigators publish new data in the report 'Comparing two types of botulinum-A toxin detrusor injections in patients with severe neurogenic detrusor overactivity: a case-control study.' "To compare the efficacy of two types of botulinum toxin type A (BTX-A; Dysport, Ipsen Ltd, Slough, UK) or Botox (Allergan Inc., Irvine, CA, USA) and examine the possible dose-effect relation for Dysport in those patients, as multifocal detrusor injections with BTX-A are effective for severe neurogenic detrusor overactivity in adults. This was an open-label, observational case-control study comparing Dysport and Botox, and the dose-effect relation for Dysport," researchers in Aachen, ...
Related newspaper, magazine, and journal articles:
|
|
Article: Dysport Added as a Procedure on ...
PRWeb;
June 19, 2009 ;
700+ words
... ... 2009 (PRWeb.com via COMTEX) -- Dysport (http://www.americanhealthandbeauty ... com/plastic%20surgery/procedures/Dysport/)(TM), a new cosmetic injectable ... AmericanHealthandBeauty.com has added Dysport to their list of cosmetic and aesthetic ...
|
|